Heart Attack News and Research

RSS

TWILIGHT trial: Brilinta reduces bleeding compared to dual therapy in high-risk coronary patients

Results from two subgroup analyses of the Phase IV independent TWILIGHT trial funded by AstraZeneca showed Brilinta (ticagrelor) monotherapy reduced the risk of clinically relevant bleeding over 12 months compared to aspirin plus Brilinta in high-risk coronary patients.

From AstraZeneca 30 Mar 2020

New microfluidic chip can mimic hypoxic conditions after a heart attack

Researchers led by biomedical engineers at Tufts University invented a microfluidic chip containing cardiac cells that is capable of mimicking hypoxic conditions following a heart attack - specifically when an artery is blocked in the heart and then unblocked after treatment.

30 Mar 2020

Taking ticagrelor alone better for patients with complex heart disease

Patients with complex heart disease who stopped taking aspirin three months after the insertion of one or more coronary stents and then took the anti-platelet medication ticagrelor alone for a year had fewer episodes of bleeding and no increase in heart attacks, stroke or other adverse events caused by blockages in the arteries, compared with patients who took both aspirin and ticagrelor over the same period.

30 Mar 2020

10-year follow-up study shows safety, efficacy of stenting compared with bypass surgery

In a study with the longest follow-up to date of patients with a high-risk form of heart disease known as left main coronary artery disease (LMCAD), researchers found no significant differences in rates of death, heart attack or stroke between patients who were treated with a stent and those who underwent heart bypass surgery.

30 Mar 2020

Treatment with ticagrelor alone reduces adverse events in patients with diabetes

Patients with diabetes who stopped taking aspirin three months after the insertion of a coronary stent and then took the anti-platelet medication ticagrelor alone for a year had fewer episodes of bleeding and no increase in heart attacks, stroke or other adverse events caused by blockages in the arteries, compared with patients who took both aspirin and ticagrelor for a year.

30 Mar 2020

Low-dose rivaroxaban reduces adverse heart events in symptomatic PAD post-intervention

People with symptomatic peripheral artery disease who took the blood thinner rivaroxaban with aspirin after undergoing a procedure to treat blocked arteries in the leg (lower extremity revascularization) had a 15% reduction in the risk of major adverse limb and cardiovascular events when compared with those receiving aspirin alone, according to research presented at the American College of Cardiology's Annual Scientific Session Together with World Congress of Cardiology.

30 Mar 2020

Use of radial artery in heart bypass surgery associated with better patient outcomes

Patients undergoing heart bypass surgery lived longer and had better outcomes when surgeons used a segment of an artery from their arm, called the radial artery, instead of a vein from their leg, called the saphenous vein, to create a second bypass, according to research presented at the American College of Cardiology's Annual Scientific Session Together with World Congress of Cardiology.

30 Mar 2020

Trials find invasive surgery is no better than medication at reducing heart attack risk

Among stable ischemic heart disease patients, invasive procedures do not reduce heart attack or death risk more than medication.

30 Mar 2020

Intravenous sodium nitrite does not help out-of-hospital cardiac arrest patients

Among patients who had an out-of-hospital cardiac arrest, intravenous sodium nitrite given by paramedics during resuscitation did not significantly improve their chances of being admitted to or discharged from the hospital alive, according to research presented at the American College of Cardiology's Annual Scientific Session Together with World Congress of Cardiology.

29 Mar 2020

Adding antiplatelet therapy to oral anticoagulants raises risk for TAVR patients with atrial fibrillation

Patients with atrial fibrillation who took oral anticoagulants alone after undergoing transcatheter aortic valve replacement had a lower rate of bleeding complications without an increased risk of clotting-related complications compared to patients who took antiplatelet medication in addition to oral anticoagulants, in a trial presented at the American College of Cardiology's Annual Scientific Session Together with World Congress of Cardiology.

29 Mar 2020

New in vivo priming strategy can be an effective means to enhance cardiac repair

Human stem cells have been regarded as one of the promising cell sources for cardiac regeneration therapy.

27 Mar 2020

Highly purified fish oil therapy could prevent thousands of cardiovascular events

Researchers from the University of California, Irvine have conducted a statistical analysis that predicts more than 70,000 heart attacks, strokes and other adverse cardiovascular events could be prevented each year in the U.S. through the use of a highly purified fish oil therapy.

25 Mar 2020

Excessive salt intake weakens the immune system

A high-salt diet is not only bad for one's blood pressure, but also for the immune system. This is the conclusion of a current study under the leadership of the University Hospital Bonn.

25 Mar 2020

A high salt intake impairs immune response, study suggests

A study has shown that a high salt intake inhibits the immune system’s ability to combat bacteria.

25 Mar 2020

New molecular probes to study the behavior of opioid receptors

It could be an important step forward in the improvement of pain therapy: Thanks to newly developed molecular probes, the behavior of individual opioid receptors can now be studied in detail.

25 Mar 2020

Having a bath regularly reduces risk of cardiovascular disease

A new study, published online in the journal Heart in March 2020, reports that with hot water, it seems to be a case of washing away health problems – literally. As a result, the more a person uses hot tubs, the better in terms of cardiovascular health. In other words, soaking in hot water daily improves heart health more than having a hot tub once or twice a day.

24 Mar 2020

Heart Attack News and Research

TWILIGHT trial: Brilinta reduces bleeding compared to dual therapy in high-risk coronary patients

New microfluidic chip can mimic hypoxic conditions after a heart attack

Taking ticagrelor alone better for patients with complex heart disease

10-year follow-up study shows safety, efficacy of stenting compared with bypass surgery

Treatment with ticagrelor alone reduces adverse events in patients with diabetes

Low-dose rivaroxaban reduces adverse heart events in symptomatic PAD post-intervention

Use of radial artery in heart bypass surgery associated with better patient outcomes

Trials find invasive surgery is no better than medication at reducing heart attack risk

Intravenous sodium nitrite does not help out-of-hospital cardiac arrest patients

Adding antiplatelet therapy to oral anticoagulants raises risk for TAVR patients with atrial fibrillation

New in vivo priming strategy can be an effective means to enhance cardiac repair

Highly purified fish oil therapy could prevent thousands of cardiovascular events

Excessive salt intake weakens the immune system

A high salt intake impairs immune response, study suggests

New molecular probes to study the behavior of opioid receptors

Having a bath regularly reduces risk of cardiovascular disease

Researchers propose a stopgap measure to help Covid-19 patients in respiratory distress

Mental stress may be a stronger predictor of repeat heart attack

Mental stress may better predict repeat heart attack than physical stress

Hypertension-related deaths increase in the U.S across all age groups

Industry Focus eBook - Forensics & toxicology (2nd edition) eBook

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News